Clinical Trials Logo

Premature Birth clinical trials

View clinical trials related to Premature Birth.

Filter by:

NCT ID: NCT03630679 Completed - Healthy Clinical Trials

A Study Evaluating Sleep, Stress and Infant Nutrition Using a Chatbot

Start date: November 7, 2018
Phase:
Study type: Observational

20 parents with healthy preterm infants (born at <37 weeks of gestation), age 0-6 months and discharged from the hospital at time of enrollment and 20 parents with healthy full-term infants (born at ≥37 weeks of gestation), age 0-6 months and discharged from the hospital at time of enrollment will be enrolled to obtain records of sleep, stress, and infant nutrition from parents of infants (preterm and full-term) through interaction with the study chatbot.

NCT ID: NCT03618836 Completed - Preterm Birth Clinical Trials

Study of the Risk of PREMaturité According to the Balance of Bacterial Flora VAginale

PREMEVA2
Start date: November 2011
Phase:
Study type: Observational

Objective To compare vaginal microbiota in the first trimester of pregnancy between spontaneous preterm and term deliveries

NCT ID: NCT03602625 Completed - Risk Factors Clinical Trials

Risk Factors of Preterm Birth Born in Hospital:a Prospective Multicenter Case-control Study

RFPTB
Start date: January 1, 2018
Phase:
Study type: Observational

The purpose of this study is to explore the perinatal risk factors of preterm birth in China.

NCT ID: NCT03599167 Completed - Clinical trials for Practice Guideline of Erythrocyte Transfusion in Preterm Infant

Red Blood Cell Transfusion in Very Premature Infants and HAS 2014 Guideline

RBCPREM
Start date: January 22, 2018
Phase:
Study type: Observational

The indications that motivated the decision to transfuse (or not) were analyzed to verify compliance with HAS recommendations. Medical records from 57 premature infants < 32 weeks hospitalized between 2016 -2017 were retrospectively analysed, especially all the events related to monitoring of hemoglobin level and RBC transfusions during the first month of life. The criteria (postnatal age, rate of haemoglobin, type of breathing assistance, oxygen needing, medullary regeneration) on which rely the decision process in the HAS algorithm for the RBC transfusion were also considered, as well as the final decision actually adopted for each case (transfused/ not transfused). All this made it possible to determine the kappa coefficient for evaluation of agreement with HAS new guidelines in the investigator's medical staff.

NCT ID: NCT03580252 Completed - Cerebral Palsy Clinical Trials

Reliability of Hammersmith Examination in Prediction of Neurological Outcomes (REHAPENO)

REHAPENO
Start date: March 1, 2018
Phase:
Study type: Observational

In this study workers are trying to test the correlation between Hammersmith Infant Neurological Examination and MRI brain/cranial ultrasound with early prediction of neurological developmental outcome of preterm neonates. This study is prospective cross-sectional collecting the data of patients according to daily standard medical practice

NCT ID: NCT03578783 Completed - Clinical trials for Premature Ejaculation

PSD502 in Subjects With Premature Ejaculation

Start date: December 26, 2018
Phase: Phase 2
Study type: Interventional

This study is being done to test the effect of PSD502 (the study medication) compared to placebo in subjects with premature ejaculation. PSD502 is a topical (applied to skin) anesthetic spray containing a mixture of two drugs called lidocaine and prilocaine that will be applied to the penis. Half of the subjects will receive PSD502 and half will receive placebo.

NCT ID: NCT03577587 Completed - Clinical trials for Breast Milk Production

Efficacy of Herbal Galactagogue Silitidil After Preterm Birth

Start date: August 14, 2017
Phase: N/A
Study type: Interventional

After preterm birth mothers often suffer from hypogalactia. Herbal galactogogues can be used in order to increase milk production. In this double-blind, randomized, placebo-controlled clinical trial the effect of Silitidil, an extract from milk thistle, on the postpartal milk production in mothers of very premature newborns is investigated.

NCT ID: NCT03574766 Completed - Anxiety Clinical Trials

Meditation for NICU Moms

Start date: October 17, 2018
Phase: N/A
Study type: Interventional

This project explores whether meditation increases breastmilk supply in mothers who are pumping milk for infants in the NICU. Mothers will be randomly assigned to daily meditation while pumping using an app designed for meditation for new mothers, and their breastmilk volume will be measured after one week of meditation versus a control group with measurements at the same time points. Investigators will also determine whether mediation improves breastfeeding confidence and reduces stress, anxiety and depression symptoms in these mothers. Finally investigators will examine the effect on salivary cortisol levels.

NCT ID: NCT03574350 Completed - Preterm Infant Clinical Trials

Effect on Early Somatic Growth of a Daily Kinesthetic Stimulation on Preterm Infants

KISONKAP
Start date: August 15, 2013
Phase: N/A
Study type: Interventional

Kangaroo position (KP), the essential component of the Kangaroo Mother Care (KMC) method, has been increasingly implemented, given the benefits of early skin-to-skin contact on the cerebral maturation of preterm infants. In addition it allows for parents to bond with their infants and humanize the care of fragile infants in neonatal units. Evidence on kinesthetic stimulation (KS) is scarce and currently there is no available evidence on KS during the KP. KS is associated with massage in this paper

NCT ID: NCT03570294 Completed - Premature Birth Clinical Trials

Oxidative Stress in Women Treated With Atosiban for Impending Preterm Birth

Start date: February 1, 2014
Phase: N/A
Study type: Interventional

Oxidative stress is recognized as a important factor in the pathogenesis premature birth. Preterm birth is defined as delivery before 37 completed weeks of gestation and it is the leading cause of neonatal morbidity and mortality. The investigators conducted this analysis to investigate the safety of administration of Atosiban - a reversible, competitive antagonist of the oxytocin receptor in the treatment of preterm labor and its impact on the level of oxidative stress after 48 hours of tocolytic treatment.